PAVmed Inc. (Nasdaq: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today ...

Over the course of 2025, Lucid burned through almost half of its cash reserves. It started the year with over $5 billion, and ...

Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, these businesses risk running out of capital ...

Lucid Group's price target has recently been updated from an unspecified prior level, with the new figure reflecting a fresh assessment of the stock's risk, execution progress, and market perception.

Lucid Group shares are trading lower Monday, even as the company secures a major victory in real-world testing and outlines ...

Lucid Group (LCID) reached $11.07 at the closing of the latest trading day, reflecting a -2.29% change compared to its last close.

Lucid (NASDAQ: LCID) stock continues to see volatile trading and has fallen roughly 5% over the last month. Meanwhile, shares ...

Lucid's Q3 2025 showed 2,841 tests and $7.1 million in pro forma revenues billed, but only $1.2 million could be ...

Lucid's stock price surged following news that the company is integrating automation software at one of its manufacturing ...

Lucid Group, Inc. (NASDAQ: LCID) shares surged nearly 18% on Wednesday and continued to climb on Thursday following news of ...